Valsartan/Hydrochloorthiazide Sandoz

Medicinal product

(Invented) name

Valsartan/Hydrochloorthiazide Sandoz

Active substance (s)

Valsartanas/Hidrochlorotiazidas

Strength

160 mg/12,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DA03, Valsartan and diuretics

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2017-08-23

Date of renewal

Documents

0541_01_ValsartanHydrochloorthiazideSandoz_PZPL_NL.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Valsartanas	160 mg
Hidrochlorotiazidas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
97596	83690	1083690	lizdinė plokštelė	N28		Receptinis	LT/L/17/0541/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Registruotas
	Išregistruotas
2017-08-23	Registruotas